Sitemap
February 14, 2025 Articles
Filter by Available Specialty
- AAAAI/World Allergy Organization meeting to spotlight impact of climate change on allergy
- AI-based biomarker tool may serve as a promising aid for depression screening
- All ECG 11
- All ECG 14
- All ECG 20
- All ECG 21
- All ECG 28
- All ECG 30
- All ECG 31
- Automated insulin delivery lowers HbA1c, improves time in range in type 2 diabetes
- ChatGPT ‘should be used with caution’ for common pregnancy questions
- ChatGPT 3.5 and 4 exceeded the proficiency threshold on AAOS shoulder, elbow examination
- Direct-to-consumer genetic testing for cancer predisposition can have ‘pitfalls’
- FDA approves Evrysdi tablets for spinal muscular atrophy
- FDA approves subcutaneous Merilog for glycemic control in diabetes
- FDA approves two hyaluronic acid fillers for nasolabial folds
- 'It is no wonder' the US has a maternal mortality crisis: Here's why and what can be done
- Lumevoq for LHON yields sustained visual acuity improvements at 5 years in phase 3 trial
- Miscellaneous ECG 33
- Miscellaneous ECG 35
- Mixed-reality navigation tool may yield accurate acetabular component placement in THA
- New ACR lupus nephritis guidelines reflect ‘conceptual shift’ in treatment
- NIH trial to test safety, efficacy of monoclonal antibody for dengue
- Q&A: Lipid-lowering drugs linked to increased risk for severe insect sting anaphylaxis
- Race may affect waitlisting, allograft and transplant outcomes in autosomal dominant PKD
- RapidAI may be more accurate than VizAI in detecting large vessel occlusion
- Risky pregnancies, driven by CVD risk factors, remain common for Native women
- Self-guided behavioral therapy as impactful as clinician-guided in atopic dermatitis
- Study links beta blocker use to mortality after stem cell transplantation
- Top in allergy/asthma: Disinfectant, asthma may be linked; agenda for new AAAAI president
- Trial identifies new all-oral drug regimens for rifampin-resistant TB
- VIDEO: Incorporate clinical trials to further ophthalmic career
- Vitamin D deficiency linked to more severe OSA in pediatric patients
- VIVID-2: Omvoh demonstrates ‘continued durability,’ safety in Crohn’s disease at 2 years